Literature DB >> 35877469

Corrigendum.

.   

Abstract

Entities:  

Year:  2022        PMID： 35877469      PMCID： PMC9434932          DOI： 10.1111/bjh.18304

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  1 in total

1.  Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.

Authors:  Alessandra Larocca; Xavier Leleu; Cyrille Touzeau; Joan Bladé; Agne Paner; María-Victoria Mateos; Michele Cavo; Christopher Maisel; Adrían Alegre; Albert Oriol; Anastasios Raptis; Paula Rodriguez-Otero; Amitabha Mazumder; Jacob Laubach; Omar Nadeem; Anna Sandberg; Marie Orre; Anna Torrång; Nicolaas A Bakker; Paul G Richardson
Journal:  Br J Haematol       Date:  2021-10-21       Impact factor: 8.615
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.